Search research articles
Contact Us
Filters
Showing results (121-130 of 159) with videos related to
Page
of 16
Sort By:
Chinese Journal of Cancer
|
July 3, 2013
The impact of both platinum-based chemotherapy and EGFR-TKIs on overall survival of patients with advanced non-small cell lung cancer
Jian-Wei Zhang, Yuan-Yuan Zhao, Ying Guo, et al.
Medcomm
|
March 10, 2025
PD-1/PD-L1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone as First-Line Therapy for Patients With Unfavorable Cancer of Unknown Primary: A Multicenter, Retrospective Cohort Study
Riqing Huang, Haifeng Li, Shuo Li, et al.
BMC Cancer
|
March 6, 2025
CYP2D6 polymorphisms and endoxifen concentration in Chinese patients with breast cancer
Cong Xue, Wei Yang, Anqi Hu, et al.
Cancer Communications (London, England)
|
April 23, 2026
Camrelizumab Plus Nab-paclitaxel in Patients with Previously Treated Advanced Urothelial Carcinoma: A Multicenter Phase II Study
Haifeng Li, Meiting Chen, Riqing Huang, et al.
Scientific Reports
|
June 11, 2024
Topical and oral peroxisome proliferator-activated receptor-α agonist ameliorates diabetic corneal neuropathy
Hassan Mansoor, Isabelle Xin Yu Lee, Molly Tzu-Yu Lin, et al.
Chinese Journal of Cancer
|
November 2, 2012
SPARC expression and prognostic value in non-small cell lung cancer
Yan Huang, Jing Zhang, Yuan-Yuan Zhao, et al.
BMC Cancer
|
October 19, 2023
Effect of chemotherapy alone or combined with immunotherapy for locally advanced or metastatic genitourinary small cell carcinoma: a real-world retrospective study
Riqing Huang, Meiting Chen, Haifeng Li, et al.
Oncotarget
|
September 12, 2015
PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival
Wenfeng Fang, Shaodong Hong, Nan Chen, et al.
Oncotargets and Therapy
|
October 23, 2014
Risk of treatment-related deaths with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis of 41 randomized controlled trials
Shaodong Hong, Wenfeng Fang, Wenhua Liang, et al.
Breast Cancer Research and Treatment
|
November 5, 2018
Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer
Cong Xue, Wenwen Wei, Peng Sun, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 159) with videos related to
Sort By:
Page
of 16
Chinese Journal of Cancer
|
July 3, 2013
The impact of both platinum-based chemotherapy and EGFR-TKIs on overall survival of patients with advanced non-small cell lung cancer
Jian-Wei Zhang, Yuan-Yuan Zhao, Ying Guo, et al.
Medcomm
|
March 10, 2025
PD-1/PD-L1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone as First-Line Therapy for Patients With Unfavorable Cancer of Unknown Primary: A Multicenter, Retrospective Cohort Study
Riqing Huang, Haifeng Li, Shuo Li, et al.
BMC Cancer
|
March 6, 2025
CYP2D6 polymorphisms and endoxifen concentration in Chinese patients with breast cancer
Cong Xue, Wei Yang, Anqi Hu, et al.
Cancer Communications (London, England)
|
April 23, 2026
Camrelizumab Plus Nab-paclitaxel in Patients with Previously Treated Advanced Urothelial Carcinoma: A Multicenter Phase II Study
Haifeng Li, Meiting Chen, Riqing Huang, et al.
Scientific Reports
|
June 11, 2024
Topical and oral peroxisome proliferator-activated receptor-α agonist ameliorates diabetic corneal neuropathy
Hassan Mansoor, Isabelle Xin Yu Lee, Molly Tzu-Yu Lin, et al.
Chinese Journal of Cancer
|
November 2, 2012
SPARC expression and prognostic value in non-small cell lung cancer
Yan Huang, Jing Zhang, Yuan-Yuan Zhao, et al.
BMC Cancer
|
October 19, 2023
Effect of chemotherapy alone or combined with immunotherapy for locally advanced or metastatic genitourinary small cell carcinoma: a real-world retrospective study
Riqing Huang, Meiting Chen, Haifeng Li, et al.
Oncotarget
|
September 12, 2015
PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival
Wenfeng Fang, Shaodong Hong, Nan Chen, et al.
Oncotargets and Therapy
|
October 23, 2014
Risk of treatment-related deaths with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis of 41 randomized controlled trials
Shaodong Hong, Wenfeng Fang, Wenhua Liang, et al.
Breast Cancer Research and Treatment
|
November 5, 2018
Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer
Cong Xue, Wenwen Wei, Peng Sun, et al.
Page
of 16